Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Moodys
AstraZeneca
McKesson
Merck

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

MS CONTIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Ms Contin patents expire, and what generic alternatives are available?

Ms Contin is a drug marketed by Purdue Pharma Lp and is included in one NDA.

The generic ingredient in MS CONTIN is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Drug patent expirations by year for MS CONTIN
Drug Prices for MS CONTIN

See drug prices for MS CONTIN

Drug Sales Revenue Trends for MS CONTIN

See drug sales revenues for MS CONTIN

Recent Clinical Trials for MS CONTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical University InnsbruckPhase 2
National Institute of Nursing Research (NINR)Phase 4
Ranbaxy Inc.Phase 1

See all MS CONTIN clinical trials

Pharmacology for MS CONTIN
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Anatomical Therapeutic Chemical (ATC) Classes for MS CONTIN

US Patents and Regulatory Information for MS CONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-003 Sep 12, 1989 AB RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-004 Jan 16, 1990 AB RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-001 May 29, 1987 AB RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-002 Apr 8, 1988 AB RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-005 Nov 8, 1993 AB RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MS CONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-003 Sep 12, 1989 ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-004 Jan 16, 1990 ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-005 Nov 8, 1993 ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-002 Apr 8, 1988 ⤷  Free Forever Trial ⤷  Free Forever Trial
Purdue Pharma Lp MS CONTIN morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019516-001 May 29, 1987 ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
McKesson
Dow
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.